Edition:
United States

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.38USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$0.38
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
261,246
52-wk High
$7.10
52-wk Low
$0.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Aug '18 0.41 -0.908
May '18 0.58 -0.683
Feb '18 0.33 -0.908
FY 2017 Nov '17 1.08 -0.761
Aug '17 1.19 -0.830
May '17 2.00 -0.594
Feb '17 1.24 -0.664
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Nov-19 1 5.50 5.50 5.50 19.79
Earnings (per share)
Year Ending Nov-19 1 -0.50 -0.50 -0.50 -0.83
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.78 36.27
P/E High - Last 5 Yrs. -- 45.52 51.32
P/E Low - Last 5 Yrs. -- 24.59 25.93
Beta 2.26 0.97 0.96
Price to Sales (TTM) 3.08 7.72 10.05
Price to Book (MRQ) -- 4.07 4.56
Price to Tangible Book (MRQ) -- 4.70 5.67
Price to Cash Flow (TTM) -- 24.65 26.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.73 1.57
Dividend Yield - 5 Year Avg -- 1.49 1.37
Dividend 5 Year Growth Rate -- -10.37 -7.56
Payout Ratio(TTM) -- 64.88 58.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -65.24 13.23 14.03
Sales (TTM) vs TTM 1 Yr. Ago -51.90 4.29 5.76
Sales - 5 Yr. Growth Rate 119.88 7.73 8.78
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.38 6.06 5.15
EPS (TTM) vs TTM 1 Yr. Ago 4.96 -- --
EPS - 5 Yr. Growth Rate -- 7.06 8.39
Capital Spending - 5 Yr. Growth Rate 11.97 9.50 9.43

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.20 2.54 2.54
Current Ratio (MRQ) 0.23 3.54 3.49
LT Debt to Equity (MRQ) -- 12.11 13.04
Total Debt to Equity (MRQ) -- 14.55 16.57
Interest Coverage (TTM) -20.73 45.08 40.69

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 76.60 50.54 51.06
Gross Margin - 5 Yr. Avg. -- 51.57 52.37
EBITD Margin (TTM) -477.08 -- --
EBITD - 5 Yr. Avg -151.38 17.81 17.23
Operating Margin (TTM) -503.50 8.93 -5.92
Operating Margin - 5 Yr. Avg. -161.21 13.68 12.14
Pre-Tax Margin (TTM) -519.12 9.46 -5.01
Pre-Tax Margin - 5 Yr. Avg. -188.73 14.10 12.29
Net Profit Margin (TTM) -519.12 6.16 -8.57
Net Profit Margin - 5 Yr. Avg. -188.73 10.53 8.57
Effective Tax Rate (TTM) -- 21.79 22.25
Effective Tax Rate - 5 Yr. Avg. -- 23.25 23.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 914,675,383 780,867,138
Net Income/Employee (TTM) -- 105,963,325 90,442,552
Receivable Turnover (TTM) 4.33 4.97 4.84
Inventory Turnover (TTM) 1.04 2.64 3.73
Asset Turnover (TTM) 0.39 0.89 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -202.95 10.55 10.13
Return on Assets - 5 Yr. Avg. -137.51 11.65 11.02
Return on Investment (TTM) -- 13.04 12.64
Return on Investment - 5 Yr. Avg. -429.25 15.00 14.18
Return on Equity (TTM) -- 14.06 13.67
Return on Equity - 5 Yr. Avg. -- 15.84 15.28
  1 Year 3 Year 5 Year
Sales % 144.97 -14.38 119.88
EPS (TTM) % 24.83 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Intellipharmaceutics International Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.